Shareholders Rally For New Directors As Cannabis MSO Enters $3M Asset Sale Deal
Portfolio Pulse from Jelena Martinovic
YourWay Cannabis Brands Inc. has agreed to sell Labtronix, Inc. for $3 million, structured as a secured note. The sale will relieve YourWay of all lawsuits, liabilities, and tax liabilities related to Labtronix. Shareholder Carl Saling III, holding 11% of YourWay's shares, has nominated six directors to the board, expressing concern over the company's direction and the asset sale's terms. Saling aims to halt the sale, complete an audit, and restore trading status. Trulieve Cannabis Corp. previously filed a complaint against YourWay and Labtronix for alleged kickback schemes.
December 01, 2023 | 6:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
YourWay Cannabis Brands Inc. is selling Labtronix, which could relieve financial and legal pressures but is facing internal shareholder dissent over the sale's valuation and company direction.
The sale of Labtronix could be positive by removing liabilities, but shareholder opposition suggests concerns over the sale price and strategic direction, which could create uncertainty and neutralize short-term stock impact.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Trulieve Cannabis Corp. has filed a complaint against YourWay and Labtronix for alleged kickback schemes, which could impact investor sentiment and legal risk.
The ongoing legal complaint by Trulieve against YourWay and Labtronix could negatively affect Trulieve's stock in the short term due to potential legal costs and negative publicity.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 50